Intradermal injection involves using only a fifth of the dose and makes it possible to immunize more people with the stocks of vaccines currently available.
Le Monde
The European Health Commissioner, Stella Kyriakides, described the “extremely important” decision. The European Medicines Agency (EMA) authorized, Friday, August 19, a new technique of injection of the vaccine against the variole of the monkey, which will allow more people to be immunized.
European countries can now administer, “as a temporary measure”, the Imvansne vaccine just under the upper layer of the skin – intradermal – and no longer in depth – in subcutaneous – as is the case Currently.
vaccinating “five times more people” with current stocks
This technique implies using only fifth of the dose, underlined the EMA in a press release, and makes it possible to “protect people at risk during the current epidemic of variole of the monkey, as long as the Supply with vaccines remains limited “.
This method gives the same immunity with an equivalent level of antibodies as the method used until then. On the other hand, the risk of skin irritation is higher, warned the surveillance body.
The European Commissioner Stella Kyriakides welcomed this authorization, which “allows to vaccinate five times more people with the stocks of vaccines we have” currently. “This guarantees better access to vaccination for people at risk and health professionals,” she added in a press release.